Navigation Links
PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
Date:6/4/2013

BOSTON, June 4, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the William Blair Growth Stock Conference in New York.  Josef von Rickenbach , Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 10:40 a.m.  ET on Wednesday, June 12, 2013.

PAREXEL will also be presenting at the Goldman Sachs Healthcare Conference in Ranchos Palos Verdes, CA.  James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 4:00 p.m.  PT on Wednesday, June 12, 2013.

A live webcast of the presentations will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website until September 12, 2013.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 78 locations in 52 countries around the world and has 14,400 employees.  For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL, Perceptive Informatics, LIQUENT, and HERON are registered trademarks of PAREXEL International Corporation or its affiliates.

Contact:
Jill Baker , Corporate Vice President, Investor Relations
PAREXEL International
Tel: +781-434-4118
Email: Jill.Baker@parexel.com

 


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL International To Present At Jefferies Healthcare Conference
2. PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
5. PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference
6. PAREXEL International To Present At Citi Global Healthcare Conference
7. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
8. PAREXEL International To Present At Oppenheimer Healthcare Conference
9. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
10. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 4, 2016 Global ... pages, profiling 09 key companies and supported with ... and in-depth study on the current state of ... of the industry including definitions, classifications, applications and ... is provided for the international market including development ...
(Date:5/3/2016)... 3, 2016 BioNovus Innovations LLC and ... Advancing Medical Innovation (IAMI) today announced a new ... and medical devices. An agreement between ... to license, develop and commercialize medical innovations advanced ... "This partnership represents a significant advance in our ...
(Date:5/3/2016)... May 4, 2016 Research and ... Cancer Stem Cell Therapy Market Outlook 2020" report ... ) , ,Recombinant technology has improved significantly in ... to be developed in coming years. Many cancer drugs ... stem cell therapies are also expected to be developed ...
Breaking Medicine Technology:
(Date:5/3/2016)... Minnesota (PRWEB) , ... May 04, 2016 , ... ... more than 40 national and global construction firms representing the Construction Industry Safety ... have joined forces with one purpose: to inspire everyone in the industry to ...
(Date:5/3/2016)... (PRWEB) , ... May 04, 2016 , ... ... for cancer. That message is reaching the global health community through expanding activities ... the burden of cancer in the resource-limited countries. , In support ...
(Date:5/3/2016)... , ... May 04, 2016 , ... The National ... inductee into its VIP Woman of the Year Circle. She is recognized with this ... for professional women, boasting more than 850,000 members and over 200 operating Local Chapters. ...
(Date:5/3/2016)... Viejo, CA (PRWEB) , ... May 03, 2016 , ... ... in Final Cut Pro X. Pixel Film Studios’ titles allow users to add a ... and basic elements such as boxes, lines and accents. To add greater contrast, all ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... Journal, patients report dissatisfaction with numerous issues related to medical care in the ... billing, and poor bedside manner from hospital staff. Commenting on this article, the ...
Breaking Medicine News(10 mins):